NCT05909566
Respiratory Support and Treatment for Efficient and Cost-Effective Care
Active, Not Recruiting
NAUp to 2InterventionalTreatmentChristopher HorvatInvestigator-initiated
~362 participants
Updated 2026-07-21 on ClinicalTrials.gov
What's tested:Clinical Decision Support (CDS)HHFNC Weaning
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
HFNC duration
Measured over Timeframe consists of a start time of either randomization or the last documentation of positive pressure ventilation (whichever is later) and the last documentation of HFNC in the electronic flowsheet, up to 30 days
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Study leadership
- Christopher Horvat, MD · PRINCIPAL_INVESTIGATOR · UPMC Children's Hospital of Pittsburgh
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
\<2 years of age Bronchiolitis WOB Score \>2
Exclusion
Immunocompromised
Immunosuppressed
Chronic lung disease
Congenital heart disease with baseline cardiorespiratory manifestations
What this trial measures
- HFNC durationTimeframe consists of a start time of either randomization or the last documentation of positive pressure ventilation (whichever is later) and the last documentation of HFNC in the electronic flowsheet, up to 30 days
Amount of time patient is on HFNC